Syndromic Surveillance for Meaningful Use: Inpatient and Ambulatory Clinical Care Data
PROJECT OVERVIEW
Current Activity:
Past Activities:
Call for Nominations to the Meaningful Use Workgroup
Call for Potential Uses of Public Health Syndromic Surveillance Data
- Preliminary Analysis of Stakeholder Response to the "Call for Potential Uses of Public Health Syndromic Surveillance"
- Preliminary Data: De-identified Stakeholder Responses
Complete Timeline: Process Details
THE OPPORTUNITY
Public health syndromic surveillance using inpatient or ambulatory clinical care data is a relatively new practice. As eligible professionals and hospitals adopt, implement, and upgrade their EHR systems through the CMS EHR Incentive programs (a.k.a., Meaningful Use programs), there is an opportunity for public health authorities to routinely receive health data from settings other than emergency departments and urgent care centers. Public health surveillance, and other key stakeholders, can play an important role in determining how to advance syndromic surveillance practice through Meaningful Use policy.
Given the number of factors and complex relationships that affect EHR data quality, a collaborative approach that includes public health, healthcare and EHR technology developers is the best way to determine how EHR data can be meaningfully used for surveillance. In late-2010, ISDS convened a group of syndromic surveillance experts, and gathered significant stakeholder input to develop guidelines and standards for syndromic surveillance using Emergendy Department and Urgent Care patient encounter data. These recommendations have been translated into a Public Heatlh Information Network Messaging Guide for Syndromic Surveillance, that is being used by the Office of the Coordinator for Health Information Technology (ONC) to clarify the public health surveillance measure.
ABOUT THE PROJECT
Recommendation Process
The Syndromic Surveillance Meaningful Use: Inpatient and Ambulatory Care Data project seeks to expand ISDS's previous meaningful use recommendation through a community consensus-driven process. Given the novelty of syndromic surveillance using these data, and the need to identify a base level of practice for the Meaningful Use programs, ISDS will use a three-phase, iterative development process that will solicit stakeholder input at project initiation and while recommendations are formulated.
Funding
This project is supported under a contract provided by the U.S. Centers for Disease Control and Prevention, Division of Notifiable Diseases and Healthcare Information.
Project Introduction Webinar
November 8, 2011 at 12:30pm - 1:30pm ET
Charlie Ishikawa, MSPH, Associate Director of Public Health Programs
Presentation Slides
View the recorded webinar below.
Related ISDS Work
Contact Information
For further information, contact Charlie Ishikawa, MSPH at 617-779-0886, or via email meaningfuluse@syndromic.org.